Global pharmaceutical major Johnson & Johnson (J&J) has officially chosen Hyderabad for its latest Global Capability Center (GCC).
The facility, under the company’s Innovative Medicine division, is being established at RMZ Nexity in HITEC City, strengthening the city’s reputation as a preferred destination for global healthcare and life sciences firms.
According to early reports, the GCC aims to support J&J’s operations in research, digital innovation, data analytics, and business transformation.
While the company has not yet issued an official statement, multiple J&J job openings were recently spotted in Hyderabad across technology, regulatory, and R&D roles, hinting at large-scale recruitment.
Unconfirmed sources indicate that the GCC is already operational and onboarding teams as part of its phased expansion plan.
Hyderabad continues to attract major global corporations in the life sciences sector, with J&J joining a long list of international pharma and biotech companies that have set up operations in the city — including Novartis, Sanofi, Bristol Myers Squibb, Roche, and AstraZeneca.
The development marks another milestone for Hyderabad’s “Genome Valley to HITEC City” corridor, reinforcing its position as one of the top global hubs for pharmaceuticals, biotechnology, and healthcare innovation.